Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0002
0.0000
(0.00%)
At close: February 28 at 3:00:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ATWOOD BRIAN G Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 23, 2016 | -- |
| GILLIS STEVEN Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 23, 2016 | -- |
| ULEVITCH RICHARD J Director | Purchase | May 23, 2016 | -- |
Related Tickers
REPL Replimune Group, Inc.
12.68
+0.36%
KURA Kura Oncology, Inc.
7.71
+0.78%
SNDX Syndax Pharmaceuticals, Inc.
15.64
+2.36%
AUTL Autolus Therapeutics plc
1.7300
-1.14%
SYRS Syros Pharmaceuticals, Inc.
0.1432
-0.83%
VSTM Verastem, Inc.
5.60
+3.04%
APTO Aptose Biosciences Inc.
3.1900
-1.85%
RIGL Rigel Pharmaceuticals, Inc.
23.06
+5.88%
APLS Apellis Pharmaceuticals, Inc.
25.15
-3.27%
KPTI Karyopharm Therapeutics Inc.
7.95
-4.79%